These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
500 related articles for article (PubMed ID: 29894577)
21. A dermocosmetic product containing the sap of oat plantlets and Garcinia mangostana extract improves the clinical signs of acne. Carballido F; Philippe A; Maitre M; Lauze C; Chanssard N; Garidou L; Duplan H; Tan J J Eur Acad Dermatol Venereol; 2024 Aug; 38 Suppl 7():12-20. PubMed ID: 39051131 [TBL] [Abstract][Full Text] [Related]
22. Recent advances in understanding Platsidaki E; Dessinioti C F1000Res; 2018; 7():. PubMed ID: 30613388 [TBL] [Abstract][Full Text] [Related]
23. Transconjugation of erm(X) conferring high-level resistance of clindamycin for Cutibacterium acnes. Aoki S; Nakase K; Hayashi N; Noguchi N J Med Microbiol; 2019 Jan; 68(1):26-30. PubMed ID: 30431414 [TBL] [Abstract][Full Text] [Related]
24. Acne cream reduces the deep Cutibacterium acnes tissue load before elective open shoulder surgery: a randomized controlled pilot trial. Unterfrauner I; Wieser K; Catanzaro S; Uçkay I; Bouaicha S J Shoulder Elbow Surg; 2022 May; 31(5):897-905. PubMed ID: 35158064 [TBL] [Abstract][Full Text] [Related]
25. Quantitative PCR of Propionibacterium acnes DNA in samples aspirated from sebaceous follicles on the normal skin of subjects with or without acne. Miura Y; Ishige I; Soejima N; Suzuki Y; Uchida K; Kawana S; Eishi Y J Med Dent Sci; 2010 Mar; 57(1):65-74. PubMed ID: 20437767 [TBL] [Abstract][Full Text] [Related]
26. Development and characterization of a 3D in vitro model mimicking acneic skin. Laclaverie M; Rouaud-Tinguely P; Grimaldi C; Jugé R; Marchand L; Aymard E; Closs B Exp Dermatol; 2021 Mar; 30(3):347-357. PubMed ID: 33354825 [TBL] [Abstract][Full Text] [Related]
27. An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: a case-control study. Jahns AC; Lundskog B; Ganceviciene R; Palmer RH; Golovleva I; Zouboulis CC; McDowell A; Patrick S; Alexeyev OA Br J Dermatol; 2012 Jul; 167(1):50-8. PubMed ID: 22356121 [TBL] [Abstract][Full Text] [Related]
29. [Biotyping of Propionibacterium acnes strains isolated from patients with acne vulgaris]. Ergin C; Kaleli I; Sahin R; Ergin S; Kaçar N Mikrobiyol Bul; 2006; 40(1-2):15-21. PubMed ID: 16775952 [TBL] [Abstract][Full Text] [Related]
30. Draft genome sequences of three multidrug-resistant Cutibacterium (formerly Propionibacterium) acnes strains isolated from acne patients, China. Zhang N; Lu Z; Ma Y J Glob Antimicrob Resist; 2017 Dec; 11():114-115. PubMed ID: 29051020 [TBL] [Abstract][Full Text] [Related]
31. Relationship between the severity of acne vulgaris and antimicrobial resistance of bacteria isolated from acne lesions in a hospital in Japan. Nakase K; Nakaminami H; Takenaka Y; Hayashi N; Kawashima M; Noguchi N J Med Microbiol; 2014 May; 63(Pt 5):721-728. PubMed ID: 24523159 [TBL] [Abstract][Full Text] [Related]
32. Increased frequency of clindamycin-resistant Cutibacterium acnes strains isolated from Japanese patients with acne vulgaris caused by the prevalence of exogenous resistance genes. Koyanagi S; Koizumi J; Nakase K; Hayashi N; Horiuchi Y; Watanabe K; Asai T; Yamazaki A; Nakazaki E; Nakaminami H J Dermatol; 2023 Jun; 50(6):793-799. PubMed ID: 36880295 [TBL] [Abstract][Full Text] [Related]
33. Characterization of acne patients carrying clindamycin-resistant Cutibacterium acnes: A Japanese multicenter study. Nakase K; Aoki S; Sei S; Fukumoto S; Horiuchi Y; Yasuda T; Tanioka M; Sugai J; Huh WW; Kakuta M; Nomoto M; Shimada T; Watanabe M; Kobayashi M; Murakami S; Takeo C; Tsubouchi R; Hayashi N; Noguchi N J Dermatol; 2020 Aug; 47(8):863-869. PubMed ID: 32424832 [TBL] [Abstract][Full Text] [Related]
34. Association of Systemic Antibiotic Treatment of Acne With Skin Microbiota Characteristics. Chien AL; Tsai J; Leung S; Mongodin EF; Nelson AM; Kang S; Garza LA JAMA Dermatol; 2019 Apr; 155(4):425-434. PubMed ID: 30758497 [TBL] [Abstract][Full Text] [Related]
35. Adult acne in women is not associated with a specific type of Cutibacterium acnes. Saint-Jean M; Corvec S; Nguyen JM; Le Moigne M; Boisrobert A; Khammari A; Dréno B J Am Acad Dermatol; 2019 Sep; 81(3):851-852. PubMed ID: 30905801 [No Abstract] [Full Text] [Related]
36. SIG1273: a new cosmetic functional ingredient to reduce blemishes and Propionibacterium acnes in acne prone skin. Fernandéz JR; Rouzard K; Voronkov M; Feng X; Stock JB; Stock M; Gordon JS; Shroot B; Christensen MS; Pérez E J Cosmet Dermatol; 2012 Dec; 11(4):272-8. PubMed ID: 23174050 [TBL] [Abstract][Full Text] [Related]
38. Safety and Efficacy of Topically Applied Selected Cutibacterium acnes Strains over Five Weeks in Patients with Acne Vulgaris: An Open-label, Pilot Study. Karoglan A; Paetzold B; Pereira de Lima J; Brüggemann H; Tüting T; Schanze D; Güell M; Gollnick H Acta Derm Venereol; 2019 Dec; 99(13):1253-1257. PubMed ID: 31573666 [TBL] [Abstract][Full Text] [Related]
39. Sensitivity of Propionibacterium acnes isolated from acne patients: comparative study of antimicrobial agents. Nishijima S; Kurokawa I; Kawabata S J Int Med Res; 1996; 24(6):473-7. PubMed ID: 8959531 [TBL] [Abstract][Full Text] [Related]
40. MLST typing of antimicrobial-resistant Propionibacterium acnes isolates from patients with moderate to severe acne vulgaris. Giannopoulos L; Papaparaskevas J; Refene E; Daikos G; Stavrianeas N; Tsakris A Anaerobe; 2015 Feb; 31():50-4. PubMed ID: 25451716 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]